Tonix's infectious disease portfolio includes TNX-801, a vaccine in development for mpox and smallpox, as well as TNX-4200 ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...

Tonix recently announced a contract with the U.S. DoD’s Defense Threat Reduction Agency (DTRA) for up to $34 million over ... overweight, diabetes, family history of heart disease) unless a heart exam ...

as well as TNX-4200 for which Tonix has a contract with the U.S. DoD’s Defense Threat Reduction Agency (DTRA) for up to $34 million over five years. TNX-4200 is a small molecule broad-spectrum ...

Tonix recently announced a contract with the U.S. DoD’s Defense Threat Reduction Agency (DTRA ... diabetes, family history of heart disease) unless a heart exam shows no problem.

A Group 1 quadcopter burns after being engaged by Aurelius Systems' laser weapon system (LWS) during tests at the Naval Postgraduate School's (NPS ...

U.S. allies around the world are warming to the idea of developing their own nuclear weapons, the result of a growing sense ...

Cao’s Career History Cao previously worked at CACI ... including division chief of the Defense Threat Reduction Agency, director of counter improvised threats – combined security transition ...

The Defense Threat Reduction Agency has begun conducting market research for professional analytical services supporting efforts to counter and deter weapons of mass destruction and other emerging ...